Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-27 22:47:28 - browse：45

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

Roche said Monday it was buying Telavant Holdings for $7.1 billion upfront, picking up a promising experimental therapy for inflammatory bowel diseases.

Telavant is owned by Roivant Sciences, with Pfizer holding a minority stake. The deal will allow Roche to develop the therapy, called RVT-3101, and, pending approval, sell it in the United States and Japan. Pfizer holds the commercial rights in other parts of the world.

The “Roi” in Roivant stands for “return on investment” and with this deal, the biotech, founded by Republican presidential candidate Vivek Ramaswamy but now run by CEO Matt Gline, certainly delivered. Last December, it essentially acquired RVT-3101 from Pfizer for $45 million and a commitment to invest in the drug’s development. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Did you have Obamacare on your GOP debate bingo card?

WSS

Sudafed saga points to U.S. issues with evaluating older drugs

Listen: Who gets the credit for GLP

Covid vaccines: Private market messier than government rollout

Did you have Obamacare on your GOP debate bingo card?

STAT Boddities: What happens to the brain when we get scared?

Menendez indictment could see pharma lose a key ally

entertainment

Wikipedia

leisure time

Apple is now the first public company to be valued at $3 trillion

Congress might make insulin pumps more accessible to the blind

Peter Hotez and the public health issue of online harassment

Too many hospitalized Covid

Drug repurposing or repositioning? The language matters

Artificial intelligence use in health care faces greater scrutiny in 2024

Tori Bowie and the unacceptable rates of Black maternal death

Menendez indictment could see pharma lose a key ally

Medical records are filled with copy

Latigo launches with $135 million for Vertex

focus

After a drawn out lobbying fight, ARPA

Covid vaccines: Private market messier than government rollout

Researchers use wearables data and AI to predict preterm birth risk

Paxlovid should be available without a positive Covid test

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Ionis has late

leisure time

entertainment

Wikipedia

explore